Filter your search
- $1,995.00 – $5,990.00Kalorama Information has been covering wound care markets for a decade, and during that time the industry has seen incredible change each year as advanced technologies enter the marketplace and become better positioned. 2010 is no exception. As a result of the growing population of the elderly, healthcare systems are challenged to treat rising incidences […]June 1, 2010$3,995.00 – $7,990.00Kalorama Information’s Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 22 suppliers, representative of […]June 1, 2010$3,995.00 – $7,990.00Kalorama Information publishes its third edition of this detailed report on the long term care industry at a time of growth but also change and concern for the long term care industry. The economy has challenged the business strategies of key players, while the recent healthcare legislation introduces changes that may affect revenues. These twin […]June 1, 2010$3,995.00 – $7,990.00Over-the-Counter (OTC) drugs are non-prescription drugs sold to consumers at pharmacies, convenience and grocery stores. These drugs include pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product. There has been a particular focus in the pharmaceutical industry on OTC drugs, and in several market research […]May 1, 2010$500.00 – $2,400.00The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries around the world, they could manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths. […]May 1, 2010$3,995.00 – $7,990.00Patient monitoring systems are emerging in response to increased healthcare needs of an aging population, new wireless technologies, better video and monitoring technologies, decreasing healthcare resources, an emphasis on reducing hospital days, and proven cost-effectiveness. Of these new high-tech patient monitoring systems, nearly all focus on some form of wireless or remote patient monitoring. Advances […]May 1, 2010$995.00 – $1,990.00RFID offers various solutions for the main segments of the healthcare industry—hospitals and nursing homes, pharmaceutical manufacturers, distributors, and pharmacies. This Kalorama Information report, The Global Market for RFID in Healthcare , defines the market for RFID opportunities in the healthcare industry, focusing on five market segments: Pharmaceutical/Blood Product Distribution and Tracking Patient/Medical Staff […]May 1, 2010$3,900.00 – $7,800.00This Kalorama Information report, Worldwide Market for Prescription Dermatological Drugs details the various categories of prescription dermatological drugs, describes the global market and identifies major market factors that may help to shape the market for treatments in the future. Full Coverage of Nine Prescription Dermatological Drug SegmentsThe global market for prescription dermatology drugs includes products […]April 1, 2010$3,995.00 – $7,990.00This Kalorama Information report – The World Anesthesia Drug Market – focuses on three primary segments of anesthesia: General Anesthesia Local Anesthesia Adjunctive Therapies in Anesthesia The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product. Forecasted […]April 1, 2010$2,995.00 – $5,990.00This report combines two of Kalorama’s latest research volumes DNA Sequencing and SNP Genotyping and Analysis Markets into one package, and includes a preface on the complementary/competitive use of SNP Analysis and whole-genome sequencing on topics and the impact of the results of GWAS on the market.April 1, 2010
